Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$3.40 /

+0.015 (+0.44%)

12:15
12/07/19
12/07
12:15
12/07/19
12:15

Mallinckrodt presents data on infantile spasms predictive model

Mallinckrodt announced findings on the use of its predictive model designed to more quickly identify infants with infantile spasms, a rare seizure disorder that typically occurs between three and seven months of age.1 The study results were reported in a poster presentation titled, "Clinical Pathways Leading to a Diagnosis of Infantile Spasms Using a Claims Database" during the Annual Meeting of the American Epilepsy Society in Baltimore. The company said, "Deductive models developed to identify the combinations of variables that predict IS prior to diagnosis and during the treatment pathway: 557 patients had greater than or equal to 2 symptoms pertaining to IS - seizures, developmental delay, lack of eye contact and lack of muscle tone - and a moderate or high severity ED visit. In this group, 55 percent of patients (n=304) had an IS diagnosis within a median 0.8 months of the triggering event. The most notable deductive combinations focused on pre-diagnosis of IS." Said Chief Medical Officer Tunde Otulana, "We're proud to present this data in support of faster diagnosis of infants during IS Awareness Week, which seeks to raise awareness of the subtle signs of IS that are often overlooked and the urgent need for prompt diagnosis and treatment. Mallinckrodt is committed to conducting research and providing critical services to help caregivers and infants with IS get the proper diagnosis as quickly as possible to enable earlier treatment intervention with the goal of improving long-term outcomes."

  • 07

    Dec

MNK Mallinckrodt
$3.40 /

+0.015 (+0.44%)

09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
09/09/19 Stifel
Mallinckrodt price target lowered to $8 from $20 at Stifel
09/05/19
Fly Intel: Top five analyst downgrades
09/05/19
Mallinckrodt cut to Market Perform at BMO Capital on opioid restructuring report

TODAY'S FREE FLY STORIES

Earnings
ANI Pharmaceuticals reports Q4 non-GAAP EPS $1.08, consensus $1.18 » 08:31
02/27/20
02/27
08:31
02/27/20
08:31
ANIP

ANI Pharmaceuticals

$59.45 /

+1.58 (+2.73%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Obalon Therapeutics reports Q4 EPS (64c), two est. (58c) » 08:31
02/27/20
02/27
08:31
02/27/20
08:31
OBLN

Obalon Therapeutics

$1.77 /

+0.035 (+2.02%)

Reports Q4 revenue $0.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Digital Realty raises quarterly dividend 4% to $1.12 per share » 08:31
02/27/20
02/27
08:31
02/27/20
08:31
DLR

Digital Realty

$130.40 /

-3.11 (-2.33%)

Digital Realty's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Carvana price target lowered to $105 from $120 at Deutsche Bank » 08:31
02/27/20
02/27
08:31
02/27/20
08:31
CVNA

Carvana

$101.66 /

-2.535 (-2.43%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Discovery says not providing FY20 OIBDA, free cash flow guidance  08:31
02/27/20
02/27
08:31
02/27/20
08:31
DISCA

Discovery

$26.50 /

-0.925 (-3.37%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Discovery sees Q3 Olympics-driven OIBDA loss ($200M)-($175M) » 08:30
02/27/20
02/27
08:30
02/27/20
08:30
DISCA

Discovery

$26.50 /

-0.925 (-3.37%)

Sees loss normalizing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Teladoc price target raised to $142 from $101 at Deutsche Bank » 08:30
02/27/20
02/27
08:30
02/27/20
08:30
TDOC

Teladoc

$116.89 /

-1.55 (-1.31%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
CRA International announces $20M expanded share repurchase program » 08:30
02/27/20
02/27
08:30
02/27/20
08:30
CRAI

CRA International

$47.76 /

-2.24 (-4.48%)

CRA announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Morgan Stanley cuts Virgin Galactic as it waits for fundamentals to 'catch up' » 08:29
02/27/20
02/27
08:29
02/27/20
08:29
SPCE

Virgin Galactic

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Sabre downgraded to Perform at Oppenheimer on higher cost structure » 08:29
02/27/20
02/27
08:29
02/27/20
08:29
SABR

Sabre

$16.15 /

-3.17 (-16.41%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Adaptimmune sees cash, cash equivalents funding operations into 2H21 » 08:29
02/27/20
02/27
08:29
02/27/20
08:29
ADAP

Adaptimmune

$3.51 /

+0.09 (+2.63%)

The Company believes that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Adaptimmune announces planned 2020 milestones » 08:29
02/27/20
02/27
08:29
02/27/20
08:29
ADAP

Adaptimmune

$3.51 /

+0.09 (+2.63%)

First Half of 2020: Full…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
CRA International sees FY20 revenue $495M-$510M, two estimates $481.21M  08:29
02/27/20
02/27
08:29
02/27/20
08:29
CRAI

CRA International

$47.76 /

-2.24 (-4.48%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Adaptimmune expects to launch ADP-A2M4 for sarcoma in 2022 » 08:28
02/27/20
02/27
08:28
02/27/20
08:28
ADAP

Adaptimmune

$3.51 /

+0.09 (+2.63%)

Based on compelling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
CRA International reports Q4 EPS 77c, consensus 78c » 08:27
02/27/20
02/27
08:27
02/27/20
08:27
CRAI

CRA International

$47.76 /

-2.24 (-4.48%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Discovery sees 2020 next-generation business revenue over $1B  08:27
02/27/20
02/27
08:27
02/27/20
08:27
DISCA

Discovery

$26.50 /

-0.925 (-3.37%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Levi Strauss announces paid family leave benefit » 08:27
02/27/20
02/27
08:27
02/27/20
08:27
LEVI

Levi Strauss

$17.77 /

-1.02 (-5.43%)

Levi Straus announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Dycom price target lowered to $38 from $47 at DA Davidson » 08:27
02/27/20
02/27
08:27
02/27/20
08:27
DY

Dycom

$30.37 /

-12.32 (-28.86%)

DA Davidson analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Atara Biotherapeutics expects to submit IND for ATA2271 in Q2 or Q3 » 08:27
02/27/20
02/27
08:27
02/27/20
08:27
ATRA

Atara Biotherapeutics

$11.22 /

+0.1 (+0.90%)

Atara is developing a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley China/Asia tech strategist to hold an analyst/industry webcast » 08:26
02/27/20
02/27
08:26
02/27/20
08:26

Head of Asia Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
TriMas sees FY20 adj. EPS $1.50-$1.60, consensus $1.70 » 08:26
02/27/20
02/27
08:26
02/27/20
08:26
TRS

TriMas

$28.08 /

+0.03 (+0.11%)

"In 2020, our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Booking Holdings price target lowered to $1,750 from $2,000 at Wedbush » 08:26
02/27/20
02/27
08:26
02/27/20
08:26
BKNG

Booking Holdings

$1,683.38 /

-44.63 (-2.58%)

Wedbush analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
TriMas reports Q4 adj. EPS 31c, consensus 38c » 08:26
02/27/20
02/27
08:26
02/27/20
08:26
TRS

TriMas

$28.08 /

+0.03 (+0.11%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
TriMas reports Q4 adj. EPS 31c, consensus 38c » 08:25
02/27/20
02/27
08:25
02/27/20
08:25
TRS

TriMas

$28.08 /

+0.03 (+0.11%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Atara Biotherapeutics to present ATA188 Phase 1a results in 1H20/2H20 » 08:25
02/27/20
02/27
08:25
02/27/20
08:25
ATRA

Atara Biotherapeutics

$11.22 /

+0.1 (+0.90%)

A Phase 1a clinical study…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.